Sotera Health Co

Balance Sheet and Liquidity As of June 30, 2025, Sotera Health had $2.3 billion of total debt, and $332 million in unrestricted cash and cash equivalents, compared to $2.3 billion in total debt and $277 million in unrestricted cash and cash equivalents as of December 31, 2024.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

As of June 30, 2025 the Company had no balance outstanding on its $600 million revolving credit facility.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

taxation of our operations and our significant leverage and how this significant leverage could adversely affect our ability to raise additional capital, limit our ability to react to challenges confronting our Company or broader changes in our industry or the economy, limit our flexibility in operating our business through restrictions contained in our debt agreements and or prevent us from meeting our obligations under our existing and future agreements governing our indebtedness.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

4 Non-GAAP Financial Measures To supplement our consolidated financial statements presented in accordance with GAAP, we consider Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net Income, Adjusted EPS, Net Debt and Net Leverage Ratio and constant currency, financial measures that are not based on any standardized methodology prescribed by GAAP.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

Our Net Debt is equal to our total debt net of unamortized debt issuance costs and debt discounts, less cash and cash equivalents.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

Our Net Leverage Ratio is equal to Net Debt divided by Adjusted EBITDA.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

Adjusted EBITDA grew nearly 10% in the quarter with approximately 160 basis points of margin expansion, driven by over 500 basis points of improvement at Nelson Labs, said Chairman and Chief Executive Officer, Michael B.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

These statements do not strictly relate to historical or current results and can be identified by words such as anticipate, appear, assume, believe, estimate, expect, forecast, intend, likely, may, plan, project, seek, should, strategy, will and other terms of similar meaning or import in connection with any discussion of future operating, financial or other performance.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

These forward-looking statements are subject to various risks, uncertainties and assumptions relating to our operations, financial results, financial condition, business, prospects, growth strategy and liquidity.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

Forward-looking statements are often characterized by the use of words such as believes, estimates, expects, projects, may, intends, plans or anticipates, or by discussions of strategy, plans or intentions.

SEC original ↗Sotera Health Co — 10-Q Quarterly report10-QAug 6, 2026

Eight individual claims have been selected as the First Plaintiff Group and are being prioritized for discovery.

SEC original ↗Sotera Health Co — 10-Q Quarterly report10-QAug 6, 2026

The Company cannot reconcile its expected Adjusted EBITDA, Tax Rate Applicable to Net Income, Adjusted Net Income and Adjusted EPS without unreasonable effort because certain items that impact net income, earnings per share and other reconciling metrics are out of the Company s control and or cannot be reasonably predicted at this time, including uncertainties caused by changes to the regulatory landscape, restructuring items and certain fair value measurements, all of which are potential adjustments for future earnings.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

Our outlook is based on current plans and expectations and is subject to several known and unknown risks and uncertainties, including those set forth below under Cautionary Note Regarding Forward-Looking Statements.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

These forward-looking statements are subject to risks, uncertainties and other factors and actual results may differ materially from those results projected in the statements.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

These forward-looking statements are subject to various risks, uncertainties and assumptions relating to our operations, financial results, financial condition, business, prospects, growth strategy and liquidity.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

taxation of our operations and our significant leverage and how this significant leverage could adversely affect our ability to raise additional capital, limit our ability to react to challenges confronting our Company or broader changes in our industry or the economy, limit our flexibility in operating our business through restrictions contained in our debt agreements and or prevent us from meeting our obligations under our existing and future agreements governing our indebtedness.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025

For additional discussion of these risks and uncertainties, please refer to the Company s filings with the Securities and Exchange Commission, such as its Annual Report on Form 10-K and quarterly reports.

SEC original ↗Sotera Health Co — Earnings release (8-K exhibit)EX-99Aug 8, 2025